Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria

ABSTRACT Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by adaptive and innate immune system dysregulation. Recent work has revealed moderate alteration of gut microbial communities in subjects with MS and in experimental, induced models. However, a mech...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Egle Cekanaviciute, Anne-Katrin Pröbstel, Anna Thomann, Tessel F. Runia, Patrizia Casaccia, Ilana Katz Sand, Elizabeth Crabtree, Sneha Singh, John Morrissey, Patrick Barba, Refujia Gomez, Rob Knight, Sarkis Mazmanian, Jennifer Graves, Bruce A. C. Cree, Scott S. Zamvil, Sergio E. Baranzini
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://doaj.org/article/6dfdfaf1ad03468387c82fa31efe09f9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6dfdfaf1ad03468387c82fa31efe09f9
record_format dspace
spelling oai:doaj.org-article:6dfdfaf1ad03468387c82fa31efe09f92021-12-02T18:39:45ZMultiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria10.1128/mSystems.00083-182379-5077https://doaj.org/article/6dfdfaf1ad03468387c82fa31efe09f92018-10-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSystems.00083-18https://doaj.org/toc/2379-5077ABSTRACT Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by adaptive and innate immune system dysregulation. Recent work has revealed moderate alteration of gut microbial communities in subjects with MS and in experimental, induced models. However, a mechanistic understanding linking the observed changes in the microbiota and the presence of the disease is still missing. Chloroform-resistant, spore-forming bacteria, which primarily belong to the classes Bacilli and Clostridia in the phylum Firmicutes, have been shown to exhibit immunomodulatory properties in vitro and in vivo, but they have not yet been characterized in the context of human disease. This study addresses the community composition and immune function of this bacterial fraction in MS. We identify MS-associated spore-forming taxa (primarily in the class Clostridia) and show that their presence correlates with impaired differentiation of IL-10-secreting, regulatory T lymphocytes in vitro. Colonization of antibiotic-treated mice with spore-forming bacteria allowed us to identify some bacterial taxa favoring IL-10+ lymphocyte differentiation and others inducing differentiation of proinflammatory, IFN-γ+ T lymphocytes. However, when fed into antibiotic-treated mice, both MS and control-derived spore-forming bacteria were able to induce similar IL-10-expressing Treg immunoregulatory responses, thus ameliorating symptoms of experimental allergic encephalomyelitis (EAE). Our analysis also identified Akkermansia muciniphila as a key organism that may interact either directly or indirectly with spore-forming bacteria to exacerbate the inflammatory effects of MS-associated gut microbiota. Thus, changes in the spore-forming fraction may influence T lymphocyte-mediated inflammation in MS. This experimental approach of isolating a subset of microbiota based on its functional characteristics may be useful to investigate other microbial fractions at greater depth. IMPORTANCE To address the impact of microbiome on disease development, it is essential to go beyond a descriptive study and evaluate the physiological importance of microbiome changes. Our study integrates computational analysis with in vitro and in vivo exploration of inflammatory properties of spore-forming microbial communities, revealing novel functional correlations. We specifically show that while small differences exist between the microbiomes of MS patients and healthy subjects, these differences are exacerbated in the chloroform-resistant fraction. We further demonstrate that, when purified from MS patients, this fraction is correlated with impaired immunomodulatory responses in vitro. Author Video: An author video summary of this article is available.Egle CekanaviciuteAnne-Katrin PröbstelAnna ThomannTessel F. RuniaPatrizia CasacciaIlana Katz SandElizabeth CrabtreeSneha SinghJohn MorrisseyPatrick BarbaRefujia GomezRob KnightSarkis MazmanianJennifer GravesBruce A. C. CreeScott S. ZamvilSergio E. BaranziniAmerican Society for Microbiologyarticleimmune mechanismsmultiple sclerosisspore-forming bacteriaMicrobiologyQR1-502ENmSystems, Vol 3, Iss 6 (2018)
institution DOAJ
collection DOAJ
language EN
topic immune mechanisms
multiple sclerosis
spore-forming bacteria
Microbiology
QR1-502
spellingShingle immune mechanisms
multiple sclerosis
spore-forming bacteria
Microbiology
QR1-502
Egle Cekanaviciute
Anne-Katrin Pröbstel
Anna Thomann
Tessel F. Runia
Patrizia Casaccia
Ilana Katz Sand
Elizabeth Crabtree
Sneha Singh
John Morrissey
Patrick Barba
Refujia Gomez
Rob Knight
Sarkis Mazmanian
Jennifer Graves
Bruce A. C. Cree
Scott S. Zamvil
Sergio E. Baranzini
Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria
description ABSTRACT Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by adaptive and innate immune system dysregulation. Recent work has revealed moderate alteration of gut microbial communities in subjects with MS and in experimental, induced models. However, a mechanistic understanding linking the observed changes in the microbiota and the presence of the disease is still missing. Chloroform-resistant, spore-forming bacteria, which primarily belong to the classes Bacilli and Clostridia in the phylum Firmicutes, have been shown to exhibit immunomodulatory properties in vitro and in vivo, but they have not yet been characterized in the context of human disease. This study addresses the community composition and immune function of this bacterial fraction in MS. We identify MS-associated spore-forming taxa (primarily in the class Clostridia) and show that their presence correlates with impaired differentiation of IL-10-secreting, regulatory T lymphocytes in vitro. Colonization of antibiotic-treated mice with spore-forming bacteria allowed us to identify some bacterial taxa favoring IL-10+ lymphocyte differentiation and others inducing differentiation of proinflammatory, IFN-γ+ T lymphocytes. However, when fed into antibiotic-treated mice, both MS and control-derived spore-forming bacteria were able to induce similar IL-10-expressing Treg immunoregulatory responses, thus ameliorating symptoms of experimental allergic encephalomyelitis (EAE). Our analysis also identified Akkermansia muciniphila as a key organism that may interact either directly or indirectly with spore-forming bacteria to exacerbate the inflammatory effects of MS-associated gut microbiota. Thus, changes in the spore-forming fraction may influence T lymphocyte-mediated inflammation in MS. This experimental approach of isolating a subset of microbiota based on its functional characteristics may be useful to investigate other microbial fractions at greater depth. IMPORTANCE To address the impact of microbiome on disease development, it is essential to go beyond a descriptive study and evaluate the physiological importance of microbiome changes. Our study integrates computational analysis with in vitro and in vivo exploration of inflammatory properties of spore-forming microbial communities, revealing novel functional correlations. We specifically show that while small differences exist between the microbiomes of MS patients and healthy subjects, these differences are exacerbated in the chloroform-resistant fraction. We further demonstrate that, when purified from MS patients, this fraction is correlated with impaired immunomodulatory responses in vitro. Author Video: An author video summary of this article is available.
format article
author Egle Cekanaviciute
Anne-Katrin Pröbstel
Anna Thomann
Tessel F. Runia
Patrizia Casaccia
Ilana Katz Sand
Elizabeth Crabtree
Sneha Singh
John Morrissey
Patrick Barba
Refujia Gomez
Rob Knight
Sarkis Mazmanian
Jennifer Graves
Bruce A. C. Cree
Scott S. Zamvil
Sergio E. Baranzini
author_facet Egle Cekanaviciute
Anne-Katrin Pröbstel
Anna Thomann
Tessel F. Runia
Patrizia Casaccia
Ilana Katz Sand
Elizabeth Crabtree
Sneha Singh
John Morrissey
Patrick Barba
Refujia Gomez
Rob Knight
Sarkis Mazmanian
Jennifer Graves
Bruce A. C. Cree
Scott S. Zamvil
Sergio E. Baranzini
author_sort Egle Cekanaviciute
title Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria
title_short Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria
title_full Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria
title_fullStr Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria
title_full_unstemmed Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria
title_sort multiple sclerosis-associated changes in the composition and immune functions of spore-forming bacteria
publisher American Society for Microbiology
publishDate 2018
url https://doaj.org/article/6dfdfaf1ad03468387c82fa31efe09f9
work_keys_str_mv AT eglecekanaviciute multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT annekatrinprobstel multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT annathomann multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT tesselfrunia multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT patriziacasaccia multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT ilanakatzsand multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT elizabethcrabtree multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT snehasingh multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT johnmorrissey multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT patrickbarba multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT refujiagomez multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT robknight multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT sarkismazmanian multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT jennifergraves multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT bruceaccree multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT scottszamvil multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
AT sergioebaranzini multiplesclerosisassociatedchangesinthecompositionandimmunefunctionsofsporeformingbacteria
_version_ 1718377743691808768